3.96
price up icon0.00%   0.00
after-market Dopo l'orario di chiusura: 3.96
loading

Kezar Life Sciences Inc Azioni (KZR) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
18.24%
17.63
21.56 21.95 23.38 23.71
Operating Income/Loss
18.24%
-17.63
-21.56 -21.95 -23.38 -23.71
Income/Loss From Continuing Operations Before Tax
18.11%
-16.56
-20.22 -20.31 -21.55 -21.66
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
18.11%
-16.56
-20.22 -20.31 -21.55 -21.66
Net Income/Loss
18.11%
-16.56
-20.22 -20.31 -21.55 -21.66
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
222.77K%
7.3057
0.00328 7.2962 72.85 72.80
Diluted Average Shares
222.77K%
7.3057
0.00328 7.2962 72.85 72.80
Basic Earnings Per Share
18.05%
-2.27
-2.77 -2.78 -0.30 -0.30
Diluted Earnings Per Share
18.05%
-2.27
-2.77 -2.78 -0.30 -0.30
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$24.78
price up icon 0.98%
$84.84
price up icon 1.00%
$24.80
price down icon 8.06%
$103.01
price down icon 1.70%
$134.53
price up icon 1.79%
biotechnology ONC
$300.14
price down icon 2.84%
Capitalizzazione:     |  Volume (24 ore):